From the Journals

Oral tecovirimat for smallpox shows efficacy in animals, safety in humans


 

FROM THE NEW ENGLAND JOURNAL OF MEDICINE

Dr. Grosenbach and his coauthors reported a disclosure related to Biomedical Advanced Research and Development Authority (BARDA), grants from NIH during the conduct of the study, and personal fees from SIGA Technologies outside the submitted work.

SOURCE: Grosenbach DW et al. N Engl J Med. 2018 Jul 5;379(1):44-53.

Pages

Recommended Reading

New chikungunya diagnostic assay proves quick, effective
MDedge Emergency Medicine
Striking the balance: Who should be screened for CP-CRE acquisition?
MDedge Emergency Medicine
ZMapp shows promise for Ebola treatment, but misses efficacy goal
MDedge Emergency Medicine
Lyme disease spirochete helps babesiosis gain a foothold
MDedge Emergency Medicine
Guidelines for diagnosing TB in adults, children
MDedge Emergency Medicine
SOFA score may be best to identify sepsis in the ICU
MDedge Emergency Medicine
Consider strongyloidiasis before giving oral steroids
MDedge Emergency Medicine
FDA: Fluoroquinolone use not linked to retina detachment, aortic problems
MDedge Emergency Medicine
Increasing sepsis survivorship creates new challenges
MDedge Emergency Medicine
NIH launches early Ebola treatment trial
MDedge Emergency Medicine